We’ve learned a lot in 2020 about where the future of healthcare is headed. There’s little question that you’ll want to invest in precision medicine. By precision medicine, I’m talking about drugs, devices, and services that are designed to personalize a previously one-size-fits-all treatment process.
Author: Praveen Suthrum
Gastrointestinal (GI) bleeding was observed in 3% of hospitalized COVID-19 patients, and a bleed developing during hospitalization was tied to greater mortality, a large New York cohort study found. Anticoagulation or antiplatelet agents were not risk factors for GI bleeding but neither did they protect against them, reported Arvind J. Trindade, MD, of the Feinstein Institutes for Medical Research at Northwell Health in Manhasset, New York, and colleagues.
Here are the most-read GI stories from Dec. 28 to Jan. 1. 1. GI in 2021 — What 6 gastroenterologists think is in store for the specialty2. How GI compensation changed over the last decade3. 44 GI centers that opened or were announced in 2020, by state
A new blood test can detect celiac disease with 95 percent accuracy without requiring a biopsy, in what could be a breakthrough for diagnostic testing, Celiac.com reports. An upcoming report, to be published in Gut, detailed results of the blood test. The test has 95 percent sensitivity and specificity in detecting celiac disease. The test looks for the blood levels of anti-transglutaminase antibodies. People with celiac disease have higher levels of these antibodies.
In this exclusive video, George Catinis, MD, medical director at the New Orleans Research Institute, discusses an RNA-FIT colorectal cancer screening test developed by Geneoscopy.
Information technology is an ever-evolving field where organizations are exploring specific technology trends, and CxOs are striving to adopt the changing scenarios to compose a better future for the business. The primary concern during this ongoing pandemic, is how companies will leverage those technology trends to gain organizational plasticity. We hope the below discussion will help you choose the action.
Ten years from now, gastroenterology will be completely unrecognizable from what it is today. NextServices President Praveen Suthrum published the book Scope Forward, offering insights on the structural shift in gastroenterology, private equity investment, colon cancer screening alternatives and several trends affecting the specialty in 2020. Mr. Suthrum conducted more than 30 interviews for the book and presented opinions from a number of leading experts on topics affecting the specialty.
In this exclusive video, Freddy Caldera, DO, MS, assistant professor of medicine in the division of gastroenterology and hepatology at the University of Wisconsin School of Medicine and Public Health, spoke about the two recent COVID-19 vaccines that have been authorized for emergency use.
The Centers for Medicare & Medicaid Services (CMS) created a new transitional pass-through (TPT) category and new HCPCS C code for single-use endoscopes, such as the aScope Duodeno, used in performing ERCP procedures in the hospital outpatient department. In addition, CMS has finalized approval of a New Technology Add-on Payment (NTAP) for the Ambu aScope Duodeno. CMS will provide hospitals with additional device reimbursement when the aScope Duodeno is used for eligible cases in the hospital inpatient setting.
When I published my year-end forecasts last year, I started with this: Short of a “black swan” event, 2020 will see a slow but steady advance in healthcare’s digital transformation. As it turns out, I was indirectly predicting the mother of all Black Swan events, namely the pandemic. The pandemic has created what could be the next trillion-dollar opportunity – telehealth.